Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.58 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.39 |
| ▸ | FGF1 | P05230 | 1/20 | 0.39 |
| ▸ | FGF2 | P09038 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | TYR | P14679 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | SLC28A3 | Q9HAS3 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10584785 | 0.99 | CDK1 (0.57) | CDK1CCNB1CA2CA9MEN1 | |
| SCHEMBL6370670 | 0.89 | CDK1 (0.57) | CDK1CCNB1CA2CA9MEN1 | |
| Sulfuric Acid SCHEMBL6376476 | 0.86 | CDK1 (0.57) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL10405566 | 0.86 | CDK1 (0.73) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL367818 | 0.86 | CDK1 (0.73) | CDK1CCNB1CA2CA9MEN1 | |
| SCHEMBL27730848 | 0.85 | CDK1 (0.69) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL15656196 | 0.85 | CDK1 (0.71) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL5972243 | 0.85 | CDK1 (0.71) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL1001769 | 0.85 | CDK1 (0.71) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL9747719 | 0.85 | CDK1 (0.71) | CDK1CCNB1CA2CA9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 401 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226138-A9 | WATER-ACTIVATED MUCOADHESIVE COMPOSITIONS TO REDUCE INTESTINAL ABSORPTION OF NUTRIENTS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2024-07-11 | — | — | US | claimed |
| US-20240131053-A1 | WATER-ACTIVATED MUCOADHESIVE COMPOSITIONS TO REDUCE INTESTINAL ABSORPTION OF NUTRIENTS | BRIGHAM & WOMENS HOSPITAL INC (US) | 2024-04-25 | — | — | US | claimed |
| US-11894524-B2 | Positive electrode plate, and electrochemical apparatus and device associated therewith | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2024-02-06 | — | — | US | claimed |
| EP-3352738-B1 | WATER-ACTIVATED MUCOADHESIVE COMPOSITIONS TO REDUCE INTESTINAL ABSORPTION OF NUTRIENTS | BRIGHAM & WOMENS HOSPITAL INC (US) | 2024-01-17 | — | — | EP | claimed |
| US-20230310314-A1 | MUCOADHESIVE COMPOSITIONS FOR DIRECTIONAL DELIVERY OF ACTIVE AGENTS | ALTRIXBIO, INC. (US) | 2023-10-05 | — | — | US | claimed |
| EP-3979397-B1 | POSITIVE ELECTRODE PLATE AND ELECTROCHEMICAL DEVICE AND EQUIPMENT ASSOCIATED THEREWITH | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2023-09-06 | — | — | EP | claimed |
| WO-2023164706-A1 | MUCOADHESIVE COMPOSITIONS FOR DIRECTIONAL DELIVERY OF ACTIVE AGENTS | ALTRIXBIO, INC. (US) | 2023-08-31 | — | — | WO | claimed |
| US-20230141842-A1 | Compounds to Modulate Intestinal Absorption of Nutrients | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2023-05-11 | — | — | US | claimed |
| US-11524024-B2 | Compounds to modulate intestinal absorption of nutrients | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2022-12-13 | — | — | US | claimed |
| US-20220226475-A1 | WATER-ACTIVATED MUCOADHESIVE COMPOSITIONS AND METHODS OF DELIVERING BIOLOGICALLY ACTIVE SUBSTANCES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-07-21 | — | — | US | claimed |
| US-20110217249-A1 | Compositions and Methods for the Treatment of Skin Diseases and Disorders Using Antimicrobial Peptide Sequestering Compounds | ANTEIS SA (CH) | 2011-09-08 | — | — | US | claimed |
| CN-1051560-C | Method for preparing chelate of antibiotic and complex metallic salt | PLIVA PHARM & CHEM WORKS (YU) | 2000-04-19 | — | — | CN | claimed |
| CN-1041166-C | Use of chelates of antibiotics with bivalent and/or trivalent metals for the preparation of antiulcer agents | PLIVA PHARM & CHEM WORKS (YU) | 1998-12-16 | — | — | CN | claimed |
| CN-1168891-A | Method for preparing chelate of antibiotic and complex metallic salt | PLIVA PHARM & CHEM WORKS (YU) | 1997-12-31 | — | — | CN | claimed |
| EP-0737072-A1 | A METHOD OF PREVENTING OR REDUCING THE RISK OF INFECTION BY BACTERIAL PATHOGENS UTILIZING SIMPLE AND CONJUGATED DEXTRANS | Novadex Pharmaceuticals Limited (CA) | 1996-10-16 | — | — | EP | claimed |
| US-5547943-A | MIXTURE WITH POLYOXYETHYLENE GLYCOL; ANTIULCER AGENT | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 1996-08-20 | — | — | US | claimed |
| WO-1995017898-A1 | A METHOD OF PREVENTING OR REDUCING THE RISK OF INFECTION BY BACTERIAL PATHOGENS UTILIZING SIMPLE AND CONJUGATED DEXTRANS | NOVADEX PHARMACEUTICALS LIMITED (CA) | 1995-07-06 | — | — | WO | claimed |
| CN-1054534-A | Use of complexes and chelates of antibiotics with bivalent and/or trivalent metals, respectively, for the preparation of antiulcer agents, novel complexes and chelates of antibiotics with bivalent and/or trivalent metals, respectively, and method for the production thereof | PLIVA PHARM & CHEM WORKS (YU) | 1991-09-18 | — | — | CN | claimed |
| US-5023072-A | Paramagnetic/superparamagnetic/ferromagnetic sucrose sulfate compositions for magnetic resonance imaging of the gastrointestinal tract | UNIVERSITY OF NEW MEXICO (US) | 1991-06-11 | — | — | US | claimed |
| CN-1049608-A | The method of treatment tooth and supporting tissue illness thereof | BUKH MEDITEC (DK) | 1991-03-06 | — | — | CN | claimed |